Skip to main content

A problem with Yahoo!

Recently I've been experiencing a problem with Yahoo! that seems to be increasing in frequency. I'm hoping to hear from any other blind/visually impaired people encountering the same thing.

In a great and needed effort to thwart the spammers, occassionally when you hit send on a Yahoo! e-mail a screen comes up asking you to type in a set of letters and numbers that appears in a little box. The letters and numbers are made intentionally difficult to read so that automoatic spam programs can't get around them. The trouble is when you make something difficult for the general public to read, you can only imagine how hard it becomes for those of us who have low vison or are blind.

Some Web sites that use similar spam thwarting efforts have an accessability link where there's an audio file to listen to the letters and numbers. It's annoying to have to do that, but at least you can. Yahoo!, as far as I can tell, offers no such alternative.

I've e-mailed their tech support twice now and am waiting for a response.

I'm concerned if we don't address the issue now it will become a real problem for the HPS yahoo groups, not to mention the other 46 yahoo groups devoted to albinism alone - let alone all the other groups for all the other visual impairments.

It might be helpful if others complained to tech support. And, I'll let you know how it goes with them.

It seems to me that if Target can lose a lawsuit for not having a Web site accessible to the blind, then one of the leading internet search engines and e-mail providers, Yahoo! should certianly meet the same criteria to fall under the Americans with Disabilities Act.

Hopefully we can get this fixed quickly and easily with no fuss. Since my first letter went unanswered, I am a tad worried.

Comments

Popular posts from this blog

Ratner's Cheesecake

Here's another recipe from Toby! Thanks Toby......and I'll get the others posted soon! Ratner's Cheesecake and plain cookies Ratner's was a Jewish dairy restaurant in the lower East Side of Manhattan. This recipe, from my disintegrating, no longer in print Ratner's cookbook, is the closest I've ever gotten to reproducing the rich, heavy cheesecake my mother made when I was a kid. It's worth the time it takes to prepare and every last calorie. Dough Can be prepared in advance. Makes enough for two cakes. Can be frozen or used to make cookies – see recipe below. 1 cup sugar 1 teaspoon vanilla extract 1 cup shortening 1 teaspoon lemon extract 1 cup butter 2 eggs 3 cups sifted cake flour ½ teaspoon salt 2 cups all purpose flour 1 teaspoon baking powder 1. In a bowl, combine all ingredients with hands. Refrigerate 3 -4 hours, or preferably overnight. Filling (for

The next generation with Hermansky-Pudlak Syndrome

I'm so behind on posting about the trip to Puerto Rico. Since the episode of Mystery Diagnosis on Hermansky-Pudlak Syndrome ran right after we got home, it's been a little busy. These, however, are my favorite pictures from Puerto Rico. I know, not pretty senery etc - but these little guys and gals inspire me. They are the next generation of folks with HPS, and if we keep up the hard work, they will live better lives because of it. They motivate me.

Some good news about Pirfenidone

Below is a press release from Intermune, the company that makes Pirfenidone. They have essentially reviewed the various clinical trials going on, and decided that Pirfenidone is safe and well tolerated. That would pretty much go along with what we've observed in the HPS community as well. We have a few folks that have been on the drug since the late 90s and continue to do well. Of course, as a journalist, I do have to say consider the source - but at the same time, as someone in a Pirfenidone trial, it's good to know. Results of Comprehensive Safety Analysis of pirfenidone In IPF Patients Presented At European Respiratory Meeting - Analysis shows safety and tolerability of pirfenidone across four clinical trials - VIENNA, Sept. 14 /PRNewswire-FirstCall/ -- InterMune, Inc. (Nasdaq: ITMN ) today announced that the results of a comprehensive review of safety data from four clinical studies were presented at the 2009 European Respiratory Society Annual Congress in Vienna, Austria